Franklin Resources’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Franklin Resources’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,292	Closed	-$2K	–	1591
2019 Q3	$2K	Buy	7,292 +6,986	+2,283%	+$1.67M	﹤0.01%	1506
2019 Q2	$109K	Hold	306	–	–	﹤0.01%	1530
2019 Q1	$403K	Hold	306	–	–	﹤0.01%	1368
2018 Q4	$494K	Sell	306 -344	-53%	-$815K	﹤0.01%	1328
2018 Q3	$1.85M	Hold	650	–	–	﹤0.01%	1220
2018 Q2	$2.15M	Hold	650	–	–	﹤0.01%	1181
2018 Q1	$2.25M	Hold	650	–	–	﹤0.01%	1183
2017 Q4	$1.07M	Hold	650	–	–	﹤0.01%	1309
2017 Q3	$2.79M	Buy	650 +17	+3%	+$87.3K	﹤0.01%	1174
2017 Q2	$4.55M	Hold	633	–	–	﹤0.01%	1093
2017 Q1	$4.8M	Hold	633	–	–	﹤0.01%	1114
2016 Q4	$3.55M	Buy	633 +291	+85%	+$1.49M	﹤0.01%	1143
2016 Q3	$2.84M	Buy	342 +33	+11%	+$348K	﹤0.01%	1200
2016 Q2	$3.02M	Hold	309	–	–	﹤0.01%	1192
2016 Q1	$5.06M	Buy	309 +36	+13%	+$815K	﹤0.01%	1097
2015 Q4	$5.63M	Buy	+273	New	+$5.16M	﹤0.01%	1112

Other funds holding TMBR

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NFG

Norris Financial Group Greenville, South Carolina $251M AUM 48.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Franklin Resources's TMBR Position: Q4 2019 in Review

Franklin Resources sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q4 2019, closing a stake of 7,292 shares — an estimated $2K sold.

Franklin Resources first reported a position in TMBR in Q4 2015 and held it in 16 quarters. The position peaked at $5.63M in Q4 2015. 7 funds tracked by Wall St. Rank hold TMBR as of Q4 2019.

Franklin Resources reported no remaining Timber Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Franklin Resources sold 7,292 Timber Pharmaceuticals, Inc. shares in Q4 2019, an estimated $2K.
Franklin Resources first reported a position in Timber Pharmaceuticals, Inc. in Q4 2015 and held it in 16 quarters.
Franklin Resources's Timber Pharmaceuticals, Inc. position peaked at $5.63M in Q4 2015.
7 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q4 2019.

Based on Franklin Resources's 13F filing for Q4 2019, filed 12 Feb 2020.